Echo Therapeutics, Inc.
(Other OTC/NBB : ECTE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -1.11%312.560.7%$866.63m
TMOThermo Fisher Scientific, Inc. 0.24%629.101.0%$856.87m
ABTAbbott Laboratories 0.94%129.580.8%$674.99m
MDTMedtronic Plc -0.57%106.670.6%$652.47m
ISRGIntuitive Surgical, Inc. -3.34%316.410.8%$444.00m
BDXBecton, Dickinson & Co. 0.74%243.731.0%$390.89m
BSXBoston Scientific Corp. -0.83%39.271.0%$354.96m
DXCMDexCom, Inc. -7.40%518.797.8%$350.54m
SYKStryker Corp. -0.72%245.611.3%$335.76m
ALGNAlign Technology, Inc. -1.90%613.076.4%$301.87m
EWEdwards Lifesciences Corp. -1.89%107.740.4%$257.46m
AAgilent Technologies, Inc. -1.23%149.141.6%$244.60m
ZBHZimmer Biomet Holdings, Inc. -1.72%120.821.7%$231.91m
IDXXIDEXX Laboratories, Inc. -3.17%580.043.8%$214.58m
WSTWest Pharmaceutical Services, Inc. -1.47%430.951.6%$182.66m

Company Profile

Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose monitoring system for use in hospital critical care units and for people with diabetes. The Prelude® SkinPrep System, a component of their Symphony CGM System, allows for enhanced skin permeation that will enable extraction of analytes, such as glucose, and transdermal drug delivery.